Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-96 |
Epistemic_statement |
denotes |
The CD200-CD200R1 Inhibitory Signaling Pathway: Immune Regulation and Host-Pathogen Interactions |
T2 |
107-268 |
Epistemic_statement |
denotes |
The CD200:CD200R1 inhibitory signaling pathway has been implicated in playing a prominent role in limiting inflammation in a wide range of inflammatory diseases. |
T3 |
666-934 |
Epistemic_statement |
denotes |
A complete understanding of the pathways regulated by CD200R1 signaling and the diverse mechanisms that pathogens have evolved to manipulate the CD200:CD200R1 pathway can help identify clinical situations where targeting this interaction can be of therapeutic benefit. |
T4 |
935-1202 |
Epistemic_statement |
denotes |
In this review, we compare CD200R1 to other pathogen-targeted inhibitory receptors and highlight how this signaling pathway is utilized by a diverse number of pathogens and, therefore, may represent a novel targeting strategy for the treatment of infectious diseases. |
T5 |
1498-1843 |
Epistemic_statement |
denotes |
Conversely, it is essential that the host immune response be appropriately controlled to respond to and remove pathogens while avoiding excessive production of cytokines, chemical mediators such as reactive oxygen species (ROS), and the release of proteolytic enzymes all of which can lead to increased tissue damage and morbidity and mortality. |
T6 |
2221-2383 |
Epistemic_statement |
denotes |
The mechanisms by which inhibitory receptors limit the amplitude of proinflammatory responses have been described in detail (Long, 1999; Ravetch & Lanier, 2000) . |
T7 |
3408-3785 |
Epistemic_statement |
denotes |
Many inhibitory receptors also have paired activating receptors, which contain cytoplasmic immunoreceptor tyrosine-based activation motifs and associate with adaptor proteins like DNAX-activating protein of 12 kDa (DAP12) or the FcRγ chain through a positively charged residue in the transmembrane region (McVicar et al., 1998) to induce proinflammatory signaling events ( Fig. |
T8 |
3793-3927 |
Epistemic_statement |
denotes |
Pathogens can express proteins that efficiently bind to a variety of inhibitory receptors that normally distinguish self from nonself. |
T9 |
4541-4753 |
Epistemic_statement |
denotes |
Interestingly, MCMV-resistant mouse strains, but not MCMV-susceptible strains, express the activating receptor Ly49H, which also binds to m157 but initiates NK killing of the infected cells (Smith et al., 2002) . |
T10 |
4754-4854 |
Epistemic_statement |
denotes |
This suggests that virus and host together have evolved to modulate signaling through this receptor. |
T11 |
5340-5488 |
Epistemic_statement |
denotes |
Both UL18 and m144 form the three α domains typical of MHC class I molecules and both can bind to β2M (Farrell et al., 1997; Reyburn et al., 1997) . |
T12 |
5489-5614 |
Epistemic_statement |
denotes |
UL18 can bind to both CD94/NKG2 and leukocyte inhibitory receptor (LIR)-1 and it is thought that m144 may interact similarly. |
T13 |
6128-6299 |
Epistemic_statement |
denotes |
In fact, LIR-1 binds to UL18 more tightly than host class I molecules (Chapman et al., 1999) , indicating that this receptor may have evolved specifically to bind to UL18. |
T14 |
7424-7591 |
Epistemic_statement |
denotes |
Interestingly, the activation receptor NKR-P1A also recognizes RCTL, indicating that host defenses have evolved to counteract the ability of RCTL to evade recognition. |
T15 |
7592-7937 |
Epistemic_statement |
denotes |
A variety of poxviruses encode a CD47 mimic (Arase & Lanier, 2004; Cameron, Barrett, Mann, Lucas, & McFadden, 2005) , and based on evidence from other paired inhibitory/ activation receptors, as described earlier, it has been suggested that these mimics may interact with signal-regulatory protein (SIRP)α to downregulate myeloid cell functions. |
T16 |
8163-8480 |
Epistemic_statement |
denotes |
The myxoma virus CD47 mimic, M128L, is required for lethal infections in rabbits and appears to regulate macrophage activation and recruitment, as M128L-deficient virus-infected rabbits exhibit increased inducible nitric oxide synthase (iNOS)-positive cells at infection sites (Cameron, Barrett, Mann, et al., 2005) . |
T17 |
8481-8705 |
Epistemic_statement |
denotes |
The activating receptor, SIRPβ does not bind to CD47, and its ligand is unknown, but may have evolved to counteract pathogen infections and/or recognize pathogen-infected cells (Arase & Lanier, 2004; Barclay & Brown, 2006) . |
T18 |
8706-8956 |
Epistemic_statement |
denotes |
In addition to viral decoys, several bacterial strains, including S. aureus and E. coli, can bind to the mouse paired Ig-like receptors (PIRs) PIR-B and PIR-A1 and human LIR-1 to suppress macrophage proinflammatory responses (Nakayama et al., 2007) . |
T19 |
9264-9386 |
Epistemic_statement |
denotes |
These data suggest that many pathogens can take advantage of host inhibitory receptors to modulate inflammatory responses. |
T20 |
9387-9581 |
Epistemic_statement |
denotes |
CD200R1 is an Ig superfamily transmembrane glycoprotein expressed on the surface of myeloid cells; it can also be induced in certain T-cell subsets (Caserta et al., 2012; Wright et al., , 2003 . |
T21 |
9960-10185 |
Epistemic_statement |
denotes |
The regulation of CD200R1 signaling can occur by posttranslational modification-namely, phosphorylation of tyrosines in the CD200R1 cytoplasmic tail-or by the inducible expression or downregulation of either CD200R1 or CD200. |
T22 |
10186-10252 |
Epistemic_statement |
denotes |
Each of these mechanisms can ultimately be exploited by pathogens. |
T23 |
11230-11465 |
Epistemic_statement |
denotes |
This is in contrast to ITIM containing inhibitory receptors, which utilize SHPs and SHIP-1 as the major initiator proteins and Dok proteins as secondary modulators of downstream signaling (Daeron et al., 2008; Mihrshahi et al., 2009 ). |
T24 |
11898-12080 |
Epistemic_statement |
denotes |
In the cases of intracellular parasites, this can be deleterious to the pathogen as well, as these organisms benefit from the survival of the host for long-term growth and expansion. |
T25 |
12766-13000 |
Epistemic_statement |
denotes |
Certain antipathogen molecules, however, are not dampened after prolonged TLR signaling because chromatin modification allows antipathogen genes to remain responsive to TLR4 in the presence of ongoing infection (Foster et al., 2007) . |
T26 |
13778-14008 |
Epistemic_statement |
denotes |
This is likely due to the fact that CD200 KO mice exhibit an increased inflammatory phenotype in response to the TLR ligands, including significantly higher IL-6 and TNFα release and IκBα phosphor-ylation (Costello et al., 2011) . |
T27 |
14265-14412 |
Epistemic_statement |
denotes |
These data show that in the case of Toxoplasmosis, increased inflammatory responses, likely through TLR signaling, are detrimental to the pathogen. |
T28 |
14780-14859 |
Epistemic_statement |
denotes |
Virulence of L. amazonensis can be restored by treatment with soluble CD200-Fc. |
T29 |
15004-15131 |
Epistemic_statement |
denotes |
However, CD200-Fc treatment in L. major-infected WT mice shifts its virulence to that of L. amazonensis (Cortez et al., 2011) . |
T30 |
15406-15478 |
Epistemic_statement |
denotes |
Interestingly, L. amazonensis increased CD200 expression on macrophages. |
T31 |
15479-15600 |
Epistemic_statement |
denotes |
Macrophages have generally been found to express CD200R1, which can then interact with nonmyeloid cells expressing CD200. |
T32 |
15601-15755 |
Epistemic_statement |
denotes |
These findings suggest that, at least in the case of L. amazonensis, macrophages can inhibit neighboring macrophages by expressing both CD200R1 and CD200. |
T33 |
15756-15982 |
Epistemic_statement |
denotes |
Macrophages infected with intracellular pathogens can release exosomes, small vesicles containing various membrane proteins, which can provide signals to naiïve macrophages (Bhatnagar, Shinagawa, Castellino, & Schorey, 2007) . |
T34 |
15983-16081 |
Epistemic_statement |
denotes |
It may be that these exosomes contain CD200, which can then bind to CD200R1 on nearby macrophages. |
T35 |
16082-16178 |
Epistemic_statement |
denotes |
Whether or how this would occur is not clear, though it is certainly an interesting possibility. |
T36 |
16179-16278 |
Epistemic_statement |
denotes |
Alternatively, macrophages expressing CD200 may interact with activated T-cells expressing CD200R1. |
T37 |
16770-16932 |
Epistemic_statement |
denotes |
This is likely due to recognition of Neisserial LPS by TLR4, since TLR ligation can increase CD200 surface expression in macrophages (Mukhopadhyay et al., 2010) . |
T38 |
16933-17114 |
Epistemic_statement |
denotes |
These data suggest that in WT mice, CD200:CD200R1 signaling plays a role in regulating the response to N. meningitidis, but does not necessarily affect the survival of the pathogen. |
T39 |
17493-17702 |
Epistemic_statement |
denotes |
Furthermore, in patients chronically infected with Schistosoma haematobium, there was a correlation between CD200R1 expression and parasite load and almost all IL-4 secreting CD4 T-cells were CD200R1 positive. |
T40 |
17703-17878 |
Epistemic_statement |
denotes |
This suggests that chronic infections lead to increased expression of CD200 and CD200R1 and subsequently a decrease in antipathogenic mediators, allowing pathogen persistence. |
T41 |
17879-17930 |
Epistemic_statement |
denotes |
How pathogens regulate CD200 expression is unclear. |
T42 |
17931-18044 |
Epistemic_statement |
denotes |
However, studies have shown that expression of CD200 is regulated by transcription factors and enhancer elements. |
T43 |
18716-18842 |
Epistemic_statement |
denotes |
Perhaps pathogens utilize these enhancer sites and transcription factors to induce CD200 expression following TLR recognition. |
T44 |
18981-19179 |
Epistemic_statement |
denotes |
The mechanisms that pathogens employ to induce the expression of CD200R1 are also unclear, although their interaction with TLRs is one mechanism (Dentesano et al., 2012; Mukhopadhyay et al., 2010) . |
T45 |
20365-20506 |
Epistemic_statement |
denotes |
These findings indicate that coronavirus infections require a functional CD200: CD200R1 signaling interaction to limit type I IFN production. |
T46 |
21302-21498 |
Epistemic_statement |
denotes |
In WT mice, alveolar macrophages exhibit increased expression of CD200R1, which would serve to limit inflammatory responses to the virus, and thus, limit immunopathology (Snelgrove et al., 2008) . |
T47 |
21832-22060 |
Epistemic_statement |
denotes |
This is thought to occur because during the resolution phase of an influenza infection, apoptotic monocytes/macrophages in the lung express CD200 on their surface while alveolar macrophages upregulate CD200R1 surface expression. |
T48 |
22179-22321 |
Epistemic_statement |
denotes |
Interestingly, CD200R1 KO mice exhibit decreased viral pathogenesis and pathology in response to influenza infection (Goulding et al., 2011) . |
T49 |
22322-22412 |
Epistemic_statement |
denotes |
These results seem counter-intuitive compared to the previous findings with CD200 KO mice. |
T50 |
22413-22618 |
Epistemic_statement |
denotes |
However, the authors suggest that this may be due to the limited expression of the receptor, compared to the broad expression of the ligand, but further studies need to be performed in order to prove this. |
T51 |
23298-23529 |
Epistemic_statement |
denotes |
These mice also had decreased cellularity in the spleen and draining lymph nodes and this was associated with a decrease in IFNγ-producing T-cells and an increase in FoxP3+ T-regulatory cells both in lymphoid tissue and the cornea. |
T52 |
23530-23675 |
Epistemic_statement |
denotes |
Treatment also mildly reduced lesions in chronically infected mice, though this would need to be combined with another drug to prove efficacious. |
T53 |
23676-23960 |
Epistemic_statement |
denotes |
These results indicate that CD200:CD200R1 signaling plays a key role in modulating inflammation during a viral infection and provides further evidence that decreasing the inflammatory milieu following a viral infection can actually have a beneficial role for unwanted immunopathology. |
T54 |
24327-24448 |
Epistemic_statement |
denotes |
Therefore, we predicted that CD200R1 KO mice would show increased morbidity and mortality in response to HSV-1 infection. |
T55 |
24449-24604 |
Epistemic_statement |
denotes |
However, CD200R1 KO mice were markedly protected against infection and exhibited a decrease in viral titers and HSV-1 glycoprotein expression in the brain. |
T56 |
24605-24789 |
Epistemic_statement |
denotes |
Furthermore, the levels of IFNβ were decreased in both the serum and brain, suggesting that the main driving force in survival was decreased viral replication (Soberman et al., 2012) . |
T57 |
24790-24968 |
Epistemic_statement |
denotes |
Whether decreased viral titers are due to increased antipathogenic defenses in CD200R1 KO mice or due to a direct effect of CD200R1 on viral replication remains to be determined. |
T58 |
24969-25162 |
Epistemic_statement |
denotes |
When we examined the interaction of HSV-1 with thioglycollate-induced peritoneal macrophages we uncovered a potentially far more complex relationship between CD200R1 and cell signaling by TLR2. |
T59 |
25736-26009 |
Epistemic_statement |
denotes |
Perhaps the best characterized is the Kaposi's sarcoma-associated herpes-virus or human herpesvirus 8 or (HHV8) K14 gene, which encodes a viral ortholog of CD200 (vOX2) that is expressed on the surface of infected cells during the lytic phase (Foster-Cuevas et al., 2004) . |
T60 |
26192-26399 |
Epistemic_statement |
denotes |
In vitro, vOX2 can downregulate TNFα, granulocyte colony-stimulating factor (G-CSF), and monocyte chemoattractant protein-1 release from macrophages activated with IFNγ and LPS (Foster-Cuevas et al., 2004) . |
T61 |
27448-27588 |
Epistemic_statement |
denotes |
Interestingly, this inhibition was not seen when basophils were stimulated with IL-3, suggesting specificity for CD200 inhibitory functions. |
T62 |
28039-28272 |
Epistemic_statement |
denotes |
The myxoma virus CD200 ortholog, M141, can function as a global inhibitor of macrophage and lymphocyte activation, leading to increased pathology and viral spread (Cameron, Barrett, Liu, Lucas, & McFadden, 2005; Zhang et al., 2009) . |
T63 |
29052-29135 |
Epistemic_statement |
denotes |
This is thought to occur through interactions with CD200R1 but has not been proven. |
T64 |
29136-29233 |
Epistemic_statement |
denotes |
Other viruses express CD200 orthologs, but its direct role in mediating viral fitness is unclear. |
T65 |
29295-29532 |
Epistemic_statement |
denotes |
With approximately 56% identity to the host CD200 protein, e127 binds to CD200R1 with equivalent affinity, however, it does not significantly affect viral replication or myeloid activity in vitro or in vivo (Foster-Cuevas et al., 2011) . |
T66 |
29533-29741 |
Epistemic_statement |
denotes |
This suggests that although CD200 mimics provide an evolutionary advantage to a variety of pathogens, its role may not be entirely the same in each infection and its effect upon binding to CD200R1 may differ. |
T67 |
29742-30029 |
Epistemic_statement |
denotes |
It is clear, based on the number of pathogens that have evolved to exploit CD200 and CD200R1 expression as well as the widespread expression of CD200 mimics in viral genomes, that the CD200:CD200R1 signaling pathway plays a major role in host:pathogen interactions and pathogen survival. |
T68 |
30030-30180 |
Epistemic_statement |
denotes |
Understanding how these infectious agents use the CD200: CD200R1 axis to downregulate host defenses can potentially be exploited in clinical settings. |
T69 |
30181-30395 |
Epistemic_statement |
denotes |
Furthermore, it is important to completely uncover how CD200R1 regulates immune responses, both dependent and independent of CD200 ligation, as this may provide important insight in the development of therapeutics. |
T70 |
30589-30694 |
Epistemic_statement |
denotes |
This drug could also be used to treat pathogenic infections that are impacted by CD200:CD200R1 signaling. |
T71 |
30695-30967 |
Epistemic_statement |
denotes |
In addition to utilizing currently available therapeutics for the treatment of viral infections, it is an intriguing possibility to target viral CD200 orthologs to stimulate viral clearance, as opposed to blocking all signaling through targeting the host CD200 or CD200R1. |
T72 |
30968-31168 |
Epistemic_statement |
denotes |
This virus-specific targeting strategy would allow normal host immune response regulation to continue, avoiding potential immunopathology, while blocking the ability of a virus to replicate unchecked. |
T73 |
31169-31521 |
Epistemic_statement |
denotes |
Though the CD200:CD200R1 axis has been implicated to play a role in transplant tolerance (Gorczynski, 2001; Yu, Chen, & Gorczynski, 2013) , one can speculate that disrupting this relationship in posttransplant patients, or other immunosuppressed patients may actually have short-term benefit under conditions where viral infections can become an issue. |
T74 |
31642-31813 |
Epistemic_statement |
denotes |
In situations where they become difficult to control with antiviral therapy, the major option is to decrease immunosuppressive therapy and restore host antiviral defenses. |
T75 |
31979-32231 |
Epistemic_statement |
denotes |
Though pretransplant screening combined with prophy-lactic treatment with antiviral therapy has been very effective in limiting morbidity caused by these infectious agents, there are times when this is not sufficient, especially with BK and PC viruses. |
T76 |
32232-32493 |
Epistemic_statement |
denotes |
Since some of these viruses target the CD200:CD200R1 signaling pathway, and likely more, blocking the interaction of CD200 with CD200R1 using an antibody or small molecule approach could support more efficient viral clearance while preserving immunosuppression. |
T77 |
32494-32605 |
Epistemic_statement |
denotes |
There are still many questions about how CD200R1 regulates inflammatory responses in myeloid cells and T-cells. |
T78 |
32606-32761 |
Epistemic_statement |
denotes |
Only a few studies have looked at the signaling molecules within cells that associate with the cytoplasmic domain of CD200R1 following ligation with CD200. |
T79 |
32965-33088 |
Epistemic_statement |
denotes |
The concept that inhibitory receptors can be multifunctional and may be required for proinflammatory signaling has emerged. |
T80 |
33089-33326 |
Epistemic_statement |
denotes |
For example, the T-and B-cell coreceptor CD150 contains a motif in its cytoplasmic tail, called the immunoreceptor tyrosine-based switch motif (ITSM), that can recruit either inhibitory or activating molecules (Shlapatska et al., 2001) . |
T81 |
33592-33760 |
Epistemic_statement |
denotes |
Although CD200R1 has neither an ITIM nor an ITSM domain, it is possible that an alternative domain in the cytoplasmic tail can modulate anti-or proinflammatory signals. |
T82 |
34423-34763 |
Epistemic_statement |
denotes |
Most inhibitory receptors contain an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic region to recruit adaptor proteins upon activation, however the CD200R1 cytoplasmic region contains three tyrosine residues (locations listed as mouse/human), which play a role in adaptor protein interactions upon phosphorylation. |